- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$4013.09 MnMarket Estimate, 2026
$4304.84 MnMarket Forecast, 2034
$7547.15 MnCAGR, 2026–2034
7.27%Executive Summary: North America Peripheral Vascular Devices Market
- Market Scope: Comprehensive North American peripheral vascular devices market analysis covering diverse product types, material variations, regional dynamics across the U.S. and Canada, and the rapid shift toward advanced minimally invasive interventional technologies.
- Market Valuation: Valued at USD 4,013.09 million in 2025, estimated at USD 4,304.84 million in 2026, and projected to reach USD 7,547.15 million by 2034, registering a solid CAGR of 7.27% (2026–2034).
- Primary Growth Drivers: Diminishing incidences of traditional open surgeries and coronary angioplasties coupled with expanding peripheral intervention techniques, rising adoption of bioabsorbable stents to minimize restenosis, and growing demand for advanced diagnostic catheters like IVUS and OCT.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment / Benchmark Standard | Fastest-Growing Segment |
|---|---|---|
| By Product Type | Retrievable Inferior Vena Cava (IVC) Filters (established as the gold standard for treating DVT/PE in North America) | Bioabsorbable Stents (projected to witness a remarkable CAGR of 62.2% driven by breakthrough clinical studies and reduced long-term complications) |
| By Material | Resistant Materials (widely utilized across conventional permanent and scaffold devices for structural durability) | Semi-Consistent Sorts & Bio-resorbable Polymers (gaining traction due to enhanced flexibility and temporary vessel support) |
| By Country | The United States (accounts for the largest regional market share backed by dense healthcare infrastructure and high procedure volumes) | Canada (experiencing strong adoption of minimally obstructive strategies fueled by long cardiac care wait times and expanding intervention facilities) |
Major Market Players & Market Structure
Market Structure: Highly competitive and innovation-driven landscape characterized by prominent medtech corporations competing through next-generation stent development, advanced imaging catheters, and risk-mitigating retrievable filter designs.
Key Companies: Abbott Laboratories, Cordis Corporation, Medtronic, Inc., Boston Scientific Corporation, and Covidien, Inc.
North America Peripheral Vascular Devices Market Size
The North America peripheral vascular devices market size was valued at USD 4013.09 million in 2025 and is anticipated to reach USD 4304.84 million in 2026 from USD 7547.15 million by 2034, growing at a CAGR of 7.27% during the forecast period from 2026 to 2034.
The diminishing incidences of coronary angioplasties and the expanding intervention techniques have affected the surgical equipment market, mainly in North America.
The risk of restenosis in angioplasty procedures energizes the selection of novel advancements to limit post-surgical complications. Among different surgical devices, bioabsorbable stents were observed to be a breakthrough in the market. The bioabsorbable stents market is relied upon to witness a huge CAGR of 62.2% during the forecast period. The achievement accomplished during the progressing studies is additionally expected to spur market adoption.
In addition to the next-generation stent, progressed diagnostic catheters, such as optical intelligence tomography (OCT) and intravascular ultrasound (IVUS) catheters, are required to develop faster in the coming years. Compared with conventional guiding catheters, a better diagnosis of vascular health is the reason behind the critical market development. In the market, the retrievable inferior vena cava filter (IVC) possesses a remarkable market space as it turns into the best quality level for the treatment of DVT/PE in North America. Also, diminished risk of long term post-surgical complication, which is regular with changeless IVC channels, is expected to ensure a CAGR of 14.8% during the forecast time period.
Based on geography, the Canadian Peripheral Vascular Devices Market still needs a sufficient number of cardiac facilities and skilled interventionists. Also, the normal waiting time for availing heart care is horrifying in Canada; such a variable is expected to fuel the adoption of advanced minimally obstructive strategies in Canada in the coming years.
KEY MARKET PLAYERS
The eminent players leading the North American Peripheral Vascular Devices market include
- Abbott Laboratories
- Cordis Corporation
- Medtronic, Inc.
- Boston Scientific Corporation
- Covidien, Inc.
MARKET SEGMENTATION
This research report on the North America Peripheral Vascular Devices Market has been segmented & sub-segmented into the following categories.
By Product Type
- Stents
- Balloon-Expandable Stent
- Self-Expandable Stents
- Secured Stents
- Embolic Protection Devices
- Angioplasty Balloons
- Ordinary
- Cutting
- Scoring
- Medication
- Aortic Stent-Grafts
- Inferior Vena Cava Filters
- Synthetic Surgical Grafts
- Peripheral Vascular Accessory Devices
- Vascular Closure Devices
- Chronic Total Occlusion (CTO) Devices
- PTA Balloon Catheters
By Material
- Resistant
- Semi-Consistent Sorts
By Country
- The United States
- Canada
- Rest of North America